Hideyuki Nakanishi

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Pharmaceutics

ACS synthetic biology

Life (Basel, Switzerland)

Nature communications

Tokyo Medical and Dental University

Kyoto University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tokyo Medical and Dental University Feb 01 2020

Japan

Assistant Professor :: Department of Biofunction Research

Kyoto Daigaku iPS Saibo Kenkyujo Apr 01 2016 - Jan 31 2020

Japan

Postdoctoral Fellow :: Department of Life Science Frontiers

Japan Society for the Promotion of Science Apr 01 2013 - Mar 31 2016

Japan

JSPS Research Fellow (PD)

Japan Society for the Promotion of Science Apr 01 2012 - Mar 31 2013

Japan

JSPS Research Fellow (PD)

Japan Society for the Promotion of Science Apr 01 2011 - Mar 31 2012

Japan

JSPS Research Fellow (DC2)

Education History

Kyoto University Apr 01 2009 - Mar 31 2012

Japan

PHD :: Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences

Kyoto University Apr 01 2007 - Mar 31 2009

Japan

MSC :: Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences

Kyoto University Apr 01 2003 - Mar 31 2007

Japan

BSC :: Department of Drug Delivery Research

Publications

Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Hideyuki Nakanishi, Hirohide Saito, Keiji Itaka
Correction to "Versatile Design of Intracellular Protein-Responsive Translational Regulation System for Synthetic mRNA". ACS synthetic biology (2022)
Hideyuki Nakanishi, Hirohide Saito, Keiji Itaka
Correction to "Versatile Design of Intracellular Protein-Responsive Translational Regulation System for Synthetic mRNA". ACS synthetic biology 12 (1) (2022)
Hideyuki Nakanishi, Hirohide Saito, Keiji Itaka
Versatile Design of Intracellular Protein-Responsive Translational Regulation System for Synthetic mRNA. ACS synthetic biology 11 (3) (2022)
Jia Deng, Yuta Fukushima, Kosuke Nozaki, Hideyuki Nakanishi, Erica Yada, Yuki Terai, Kenji Fueki, Keiji Itaka
Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist. Pharmaceutics 14 (9) (2022)
Hideyuki Nakanishi
Protein-Based Systems for Translational Regulation of Synthetic mRNAs in Mammalian Cells. Life (Basel, Switzerland) 11 (11) (2021)
Hideyuki Nakanishi, Hirohide Saito
Caliciviral protein-based artificial translational activator for mammalian gene circuits with RNA-only delivery. Nature communications 11 (1) (2020)

Hideyuki Nakanishi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hideyuki Nakanishi